
Shire hires finance director
pharmafile | October 28, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Shire, dominic blakemore
Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance & Risk Committee.
Blakemore is Group Finance director of Compass Group. Prior to this he was the chief financial officer at Iglo Foods Group and Finance & Strategy director of Cadbury.
Blakemore spent his earlier career years at PwC (PricewaterhouseCoopers), where his work included advising pharmaceutical sector clients.
Matthew Emmens, chairman of Shire said: “The Shire Board will benefit from Dominic’s strategic and financial experience. We look forward to him joining the Board.”
Blakemore added: “Shire has an excellent track record of growth and a clear strategy. I look forward to playing a part in this growing company’s future.”
Related Content

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end
Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, …

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion
Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss …

Top Ten most popular articles on Pharmafile.com this week!
With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger …






